Contrasts, conflicts, and change: A case in cultural oncology.
Dhruva
Anand
A
Hematology-Oncology Division, San Francisco General Hospital, San Francisco, CA 94110, USA. adhruva@itsa.ucsf.edu
Cheng
Judy
J
Kwong
Myron
M
Luce
Judith A
JA
Abrams
Donald I
DI
D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D044466:Asian People / Q000208:ethnology*; D001294:Attitude to Health / Q000208:ethnology*; D016190:Carboplatin / Q000008:administration & dosage; D003466:Cultural Characteristics; D000069347:Erlotinib Hydrochloride; D005195:Family Relations / Q000208:ethnology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D010817:Physician-Patient Relations; D011799:Quinazolines / Q000627:therapeutic use; D013899:Thoracic Neoplasms / Q000188:drug therapy / Q000208:ethnology* / Q000523:psychology / Q000532:radiotherapy
D000970:Antineoplastic Agents; D011799:Quinazolines; D016190:Carboplatin; D000069347:Erlotinib Hydrochloride; D017239:Paclitaxel